Cargando…
Assessing the impact of a pharmacy-provided personalized vaccination recommendation on immunization rates of adolescents
BACKGROUND: Adolescents should receive timely doses of recommended vaccinations. The coronavirus disease 2019 (COVID-19) vaccination approval for adolescents presented an opportunity for community pharmacists to address gaps in adolescent immunization schedules. OBJECTIVES: The objectives of this re...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Pharmacists Association®. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9595482/ https://www.ncbi.nlm.nih.gov/pubmed/36424294 http://dx.doi.org/10.1016/j.japh.2022.10.017 |
_version_ | 1784815660859129856 |
---|---|
author | Herrman, Adrianna Ruisinger, Janelle F. Moore, Erin E. Melton, Brittany L. |
author_facet | Herrman, Adrianna Ruisinger, Janelle F. Moore, Erin E. Melton, Brittany L. |
author_sort | Herrman, Adrianna |
collection | PubMed |
description | BACKGROUND: Adolescents should receive timely doses of recommended vaccinations. The coronavirus disease 2019 (COVID-19) vaccination approval for adolescents presented an opportunity for community pharmacists to address gaps in adolescent immunization schedules. OBJECTIVES: The objectives of this research were to (1) identify adolescent immunization gaps, (2) identify number of patients receiving recommended vaccination(s) at the community pharmacy, and (3) determine how many vaccinations were administered after the intervention. METHODS: Three pharmacies conducted the prospective intervention. Adolescents aged 11-17 years initiating the Pfizer-BioNTech COVID-19 vaccination series were eligible to receive a personalized vaccination recommendation (PVR), which included up to 3 other vaccinations. State immunization information systems were assessed after dose 1 of the COVID-19 vaccine to create the recommendation(s) and reassessed 6 months after providing the PVR for accepted recommendations. Patient demographics and number of vaccinations administered were assessed using descriptive statistics. RESULTS: Of the 225 adolescents who received COVID-19 vaccine dose 1, 74.7%, 75.1%, and 83.1% were indicated to receive tetanus, diphtheria, and acellular pertussis (Tdap), meningococcal conjugate (MenACWY), or human papillomavirus (HPV) vaccine, respectively. Thirty-three (14.7%) adolescents were up to date on all 3 vaccinations assessed. Of the 225 adolescents, 180 returned to the same location for COVID-19 vaccine dose 2 and received a PVR. Forty-two caregivers reported that their adolescent previously received 1 or more of the recommended vaccinations, indicating that state immunization information systems were inaccurate. Six months after the PVRs were given, 24 vaccinations had been administered. CONCLUSIONS: Most adolescents presenting for a COVID-19 vaccine were indicated, according to state immunization information systems, to receive at least 1 additional vaccination. After pharmacist-provided PVR and education, vaccine uptake occurred. Considering caregiver-reported inaccuracies, pharmacists should be cognizant of potential discrepancies when providing PVRs. In addition, this study highlights the value of a state immunization information system. |
format | Online Article Text |
id | pubmed-9595482 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Pharmacists Association®. Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95954822022-10-25 Assessing the impact of a pharmacy-provided personalized vaccination recommendation on immunization rates of adolescents Herrman, Adrianna Ruisinger, Janelle F. Moore, Erin E. Melton, Brittany L. J Am Pharm Assoc (2003) Brief Report BACKGROUND: Adolescents should receive timely doses of recommended vaccinations. The coronavirus disease 2019 (COVID-19) vaccination approval for adolescents presented an opportunity for community pharmacists to address gaps in adolescent immunization schedules. OBJECTIVES: The objectives of this research were to (1) identify adolescent immunization gaps, (2) identify number of patients receiving recommended vaccination(s) at the community pharmacy, and (3) determine how many vaccinations were administered after the intervention. METHODS: Three pharmacies conducted the prospective intervention. Adolescents aged 11-17 years initiating the Pfizer-BioNTech COVID-19 vaccination series were eligible to receive a personalized vaccination recommendation (PVR), which included up to 3 other vaccinations. State immunization information systems were assessed after dose 1 of the COVID-19 vaccine to create the recommendation(s) and reassessed 6 months after providing the PVR for accepted recommendations. Patient demographics and number of vaccinations administered were assessed using descriptive statistics. RESULTS: Of the 225 adolescents who received COVID-19 vaccine dose 1, 74.7%, 75.1%, and 83.1% were indicated to receive tetanus, diphtheria, and acellular pertussis (Tdap), meningococcal conjugate (MenACWY), or human papillomavirus (HPV) vaccine, respectively. Thirty-three (14.7%) adolescents were up to date on all 3 vaccinations assessed. Of the 225 adolescents, 180 returned to the same location for COVID-19 vaccine dose 2 and received a PVR. Forty-two caregivers reported that their adolescent previously received 1 or more of the recommended vaccinations, indicating that state immunization information systems were inaccurate. Six months after the PVRs were given, 24 vaccinations had been administered. CONCLUSIONS: Most adolescents presenting for a COVID-19 vaccine were indicated, according to state immunization information systems, to receive at least 1 additional vaccination. After pharmacist-provided PVR and education, vaccine uptake occurred. Considering caregiver-reported inaccuracies, pharmacists should be cognizant of potential discrepancies when providing PVRs. In addition, this study highlights the value of a state immunization information system. American Pharmacists Association®. Published by Elsevier Inc. 2022-10-22 /pmc/articles/PMC9595482/ /pubmed/36424294 http://dx.doi.org/10.1016/j.japh.2022.10.017 Text en © 2022 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Brief Report Herrman, Adrianna Ruisinger, Janelle F. Moore, Erin E. Melton, Brittany L. Assessing the impact of a pharmacy-provided personalized vaccination recommendation on immunization rates of adolescents |
title | Assessing the impact of a pharmacy-provided personalized vaccination recommendation on immunization rates of adolescents |
title_full | Assessing the impact of a pharmacy-provided personalized vaccination recommendation on immunization rates of adolescents |
title_fullStr | Assessing the impact of a pharmacy-provided personalized vaccination recommendation on immunization rates of adolescents |
title_full_unstemmed | Assessing the impact of a pharmacy-provided personalized vaccination recommendation on immunization rates of adolescents |
title_short | Assessing the impact of a pharmacy-provided personalized vaccination recommendation on immunization rates of adolescents |
title_sort | assessing the impact of a pharmacy-provided personalized vaccination recommendation on immunization rates of adolescents |
topic | Brief Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9595482/ https://www.ncbi.nlm.nih.gov/pubmed/36424294 http://dx.doi.org/10.1016/j.japh.2022.10.017 |
work_keys_str_mv | AT herrmanadrianna assessingtheimpactofapharmacyprovidedpersonalizedvaccinationrecommendationonimmunizationratesofadolescents AT ruisingerjanellef assessingtheimpactofapharmacyprovidedpersonalizedvaccinationrecommendationonimmunizationratesofadolescents AT mooreerine assessingtheimpactofapharmacyprovidedpersonalizedvaccinationrecommendationonimmunizationratesofadolescents AT meltonbrittanyl assessingtheimpactofapharmacyprovidedpersonalizedvaccinationrecommendationonimmunizationratesofadolescents |